JOHNSON & JOHNSON (JNJ) — Moat, Quality & Fair Value

JOHNSON & JOHNSON (JNJ) has a Wide economic moat and a quality score of 80/100. It operates in the Health Care sector.

Economic moat: Wide. Its competitive advantage is anchored in Intangible Assets, and Switching Costs. A wide moat indicates durable advantages likely to protect returns on capital for many years. Learn more about how we classify moats in our guide to economic moats.

Quality score: 80/100. This score combines seven weighted pillars — returns on capital, margin strength, cash generation, financial health, durability, management, and moat & position. See how the quality score works.

Fair value: Our base owner-earnings estimate is $322.72 (range $163.56–$481.89). At $250.67, JNJ trades a 22% discount to its estimated fair value — below fair value. Read how we calculate fair value.

Management: Buy the Management. Our management grade evaluates capital allocation, shareholder returns, compensation, dilution, buyback timing, and insider ownership.

Explore the full interactive analysis for JNJ below — including the price & fair-value chart, financial statements, and the complete management evaluation. New to the framework? Start with the MoatScope guide.